US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 1,473 | 1,507 | 1,386 | 1,155 | 964 |
| Cost of Goods | 537 | 535 | 452 | 362 | 250 |
| Gross Profit | 936 | 972 | 934 | 793 | 715 |
| Operating Expenses | 1,321 | 2,564 | 1,244 | 1,197 | 831 |
| Operating Income | 152 | -1,057 | 142 | -42 | 133 |
| Interest Expense | -138 | 192 | 421 | 167 | 191 |
| Other Income | 57 | 317 | -146 | -2,264 | 384 |
| Pre-tax Income | 347 | -932 | -425 | -2,472 | 326 |
| Net Income Continuous | 347 | -932 | -425 | -2,472 | 326 |
| Net Income | $347 | $-932 | $-425 | $-2,472 | $326 |
| EPS Basic Total Ops | N/A | 0.00 | 0.00 | -0.01 | 0.24 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.25 |
| EPS Diluted Total Ops | N/A | 0.00 | 0.00 | -0.01 | 0.24 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.25 |
| EBITDA(a) | $-9 | $-923 | $383 | $50 | $135 |